Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test kit that can predict treatment and survival outcomes in kidney cancer patients. This is the first genetic test to help doctors prescribe the appropriate treatment for kidney cancer patients based on their tumour profile.  This breakthrough was recently … Continue reading First ever kidney cancer molecular test predicts patient’s survival and drug response.